VIMZORPA
Pharmaceutical preparations, namely, preparations for the treatment, control and prevention of human disorders and diseases resulting from hyperphosphatemia, hyperlipidemia, hypercholestrolemia, hyperparathyroidism, kidney dysfunction, and neurological, genetic, cardiovascular, gastrointestinal, urological, metabolic diabetic, allergy, obesity, and insulin resistance syndromes and conditions
Cancelled · October 14, 2010 · 85152532 ·
